CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer

被引：0
|
作者：
Lazaratos, Anna-Maria [1 ]
Petrecca, Kevin [2 ]
Guiot, Marie-Christine [2 ]
Dankner, Matthew [1 ]
Jerzak, Katarzyna J. [3 ]
机构：
[1] McGill Univ, Rosalind & Morris Goodman Canc Res Inst, Montreal, PQ H3A 1A3, Canada
[2] McGill Univ, Montreal Neurol Inst Hosp, Montreal, PQ H3A 1A3, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Div Med Oncol, Toronto, ON, Canada
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 07期
关键词：
BRAIN METASTASES;
D O I：
10.1016/S1470-2045(24)00261-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e282 / e282
页数：1
相关论文
共 50 条
  • [1] Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
    Li, Bob T.
    Smit, Egbert F.
    Goto, Yasushi
    Nakagawa, Kazuhiko
    Udagawa, Hibiki
    Mazieres, Julien
    Nagasaka, Misako
    Bazhenova, Lyudmila
    Saltos, Andreas N.
    Felip, Enriqueta
    Pacheco, Jose M.
    Perol, Maurice
    Paz-Ares, Luis
    Saxena, Kapil
    Shiga, Ryota
    Cheng, Yingkai
    Acharyya, Suddhasatta
    Vitazka, Patrik
    Shahidi, Javad
    Planchard, David
    Janne, Pasi A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (03): : 241 - 251
  • [2] A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer
    Lazaratos, Anna-Maria
    Bian, David J. H.
    Petrecca, Kevin
    Guiot, Marie-Christine
    Dankner, Matthew
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (12) : 3824 - 3830
  • [3] Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer
    Tjong, Michael C.
    Mak, Raymond H.
    Louie, Alexander V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1770 - 1770
  • [4] Trastuzumab deruxtecan for HER2-expressing metastatic colorectal cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : S31 - S31
  • [5] Metastatic HER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
    Yun, Karen M.
    Bazhenova, Lyudmila
    BMJ CASE REPORTS, 2023, 16 (05)
  • [6] Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
    DiPeri, Timothy P.
    Evans, Kurt W.
    Raso, Maria Gabriela
    Zhao, Ming
    Rizvi, Yasmeen Q.
    Zheng, Xiaofeng
    Wang, Bailiang
    Kirby, Bryce P.
    Kong, Kathleen
    Kahle, Michael
    Yap, Timothy A.
    Dumbrava, Ecaterina E.
    Ajani, Jaffer A.
    Fu, Siqing
    Keyomarsi, Khandan
    Meric-Bernstam, Funda
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4385 - 4398
  • [7] A Case of Metastatic HER2-Amplified Non-Small-Cell Lung Cancer (NSCLC) Treated with Trastuzumab Deruxtecan
    Yun, K.
    Bazhenova, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E38 - E38
  • [8] DESTINY-Lung01 Trial Investigators Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
    Sharayah, Ahmad
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (06) : 749 - 750
  • [9] Trastuzumab deruxtecan shows durable activity in HER2-mutant non-small cell lung cancer
    O'Rourke, Kate
    CANCER, 2022, 128 (05) : 938 - 938
  • [10] Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC)
    Pitiyarachchi, Omali
    Tan, Aaron C.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02)
12345